Osama Hussein

Osama Hussein

Auto-generated profile, based on publicly available information

Osama Hussein

Surgical Oncology Department, Mansoura University Oncology Center, Faculty of Medicine Mansoura University Mansoura Egypt

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1999 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
ADA. Denewer
A. Denewer
SKS. Kotb
S. Kotb
OHO. Hussein
O. Hussein
MEM. El‐Maadawy
M. El‐Maadawy

18 May 2017 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
KTKerstin Tiedemann
Kerstin Tiedemann
DNDamien Le Nihouannen
Damien Le Nihouannen
JFJenna E. Fong
Jenna E. Fong
OHOsama Hussein
Osama Hussein
Jake BarraletJake Barralet
Jake Barralet
SKSvetlana Komarova
Svetlana Komarova
Osteoclasts are giant bone cells formed by fusion from monocytes and uniquely capable of a complete destruction of mineralized tissues. Previously, we have demonstrated that in energy-rich environment not only osteoclast fusion index (the number of nuclei each osteoclast contains), but also cytoplasm volume per single nucleus was increased. The goal of this study was to investigate the regulation of metabolic sensor mTOR during osteoclast differentiation in energy-rich environment simulated by addition of pyruvate. We have found that in the presence of pyruvate, the proportion of mTOR associated with raptor increased, while mTOR-rictor-mediated Akt phosphorylation decreased. Inhibition of mTOR with rapamycin (10 nM) significantly interfered with all aspects of osteoclastogenesis. However rapamycin at 1 nM, which preferentially targets mTOR-raptor complex, was only effective in control cultures, while in the presence of pyruvate osteoclast fusion index was successfully increased. Inhibition of Akt drastically reduced osteoclast fusion, however in energy-rich environment, osteoclasts of comparable size were formed through increased cytoplasm growth. These data suggest that mTOR-rictor mediated Akt signaling controls osteoclast fusion, while mTOR-raptor regulation of protein translation contributes to fusion-independent cytoplasm growth. We demonstrate that depending on the bioenergetics microenvironment osteoclastogenesis can adjust to occur through preferential multinucleation or through cell growth, implying that attaining large cell size is part of the osteoclast differentiation program.

1 January 2012 in Cancer Letters
Verified
Journal Article
Closed access
OHOsama Hussein
Osama Hussein
KTKerstin Tiedemann
Kerstin Tiedemann
MMMonzur Murshed
Monzur Murshed
SKSvetlana V. Komarova
Svetlana V. Komarova

26 July 2007 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MHMohamed A. F. Hegazy
Mohamed A. F. Hegazy
AKAshraf A. Khater
Ashraf A. Khater
ASAhmed E. Setit
Ahmed E. Setit
MAMahmoud A. Amin
Mahmoud A. Amin
SKSherif Z. Kotb
Sherif Z. Kotb
ODOla T. Abdel Dayem
Ola T. Abdel Dayem

1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
ADAdel Denewer
Adel Denewer
AKAshraf Khater
Ashraf Khater
MHMohamed T Hafez
Mohamed T Hafez
OHOsama Hussein
Osama Hussein
SRSameh Roshdy
Sameh Roshdy
KMKhaled Mowafy
Khaled Mowafy
The aim of this study is to define an algorithm for the choice of reconstructive method for defects after laryngo-pharyngo-esophagectomy for hypopharyngeal carcinoma.

1 November 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
KTKerstin Tiedemann
Kerstin Tiedemann
OHOsama Hussein
Osama Hussein
GSGulzhakhan Sadvakassova
Gulzhakhan Sadvakassova
YGYubin Guo
Yubin Guo
PSPeter M. Siegel
Peter M. Siegel
SKSvetlana Komarova
Svetlana Komarova
Breast cancer commonly metastasizes to bone where its growth depends on the action of bone-resorbing osteoclasts. We have previously shown that breast cancer cells secrete factors able to directly stimulate osteoclastogenesis from receptor activator of nuclear factor kappaB ligand (RANKL)-primed precursors and that transforming growth factor-beta (TGFbeta) plays a permissive role in this process. Now, we evaluate the signaling events triggered in osteoclast precursors by soluble factors produced by MDA-MB-231 human breast carcinoma cells. In mouse bone marrow cultures and RAW 264.7 murine monocytic cells, MDA-MB-231-derived factors increased osteoclast number, size, and nucleation. These factors failed to induce Smad2 phosphorylation, and short interfering RNAs against Smad4 did not affect their ability to induce osteoclastogenesis. In contrast, MDA-MB-231 factors induced phosphorylation of p38 and ERK1/2, and pharmacological inhibitors against p38 (SB203580) and MEK1/2 (PD98059) impeded the osteoclastogenic effects of cancer-derived factors. Neutralizing antibodies against TGFbeta attenuated p38 activation, whereas activation of ERK1/2 was shortened in duration, but not decreased in amplitude. ERK1/2 phosphorylation induced by cancer-derived factors was blocked by MEK1/2 inhibitor, but not by Ras (manumycin A) or Raf (GW5074) inhibitors. Inhibition of protein kinase Calpha using Gö6976 prevented both ERK1/2 phosphorylation and osteoclast formation in response to MDA-MB-231-derived factors. Using microspectrofluorimetry of fura-2-AM-loaded osteoclast precursors, we have found that cancer-derived factors, similar to RANKL, induced sustained oscillations in cytosolic free calcium. The calcium chelator BAPTA prevented calcium elevations and osteoclast formation in response to MDA-MB-231-derived factors. Thus, we have shown that breast cancer-derived factors induce osteoclastogenesis through the activation of calcium/protein kinase Calpha and TGFbeta-dependent ERK1/2 and p38 signaling pathways.